Understanding ITPRID2: A Potential Drug Target and Biomarker (G6744)

Target Name: ITPRID2

NCBI ID: G6744

ITPRID2

Understanding ITPRID2: A Potential Drug Target and Biomarker

ITPRID2 (Immunomodulatory target protein regulated by doublecortin) is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and gastrointestinal tract. It plays a crucial role in the regulation of immune responses and has been implicated in a number of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. As a result, ITPRID2 has become a focus of interest for researchers in the field of drug development.

The ITPRID2 protein is composed of 114 amino acid residues and has a calculated molecular weight of 13.9 kDa. It is expressed in a variety of tissues, including the lungs, heart, kidneys, and gastrointestinal tract, and is also found in the bloodstream. ITPRID2 is primarily localized to the cytoplasm of cells and is not known to have any intracellular localization.

Function and regulation

The function of ITPRID2 is not well understood, but it is believed to play a role in the regulation of immune responses and in the development of certain diseases. One of the most significant functions of ITPRID2 is its role in the regulation of T cell responses. T cells are a critical part of the immune system and play a major role in the regulation of both physical and cellular immunity. ITPRID2 has been shown to regulate the development and function of T cells, including their proliferation, differentiation, and selection.

In addition to its role in T cell regulation, ITPRID2 is also thought to be involved in the regulation of inflammation and immune-mediated tissue damage. It has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6, and has been shown to interact with several different signaling pathways, including the TGF-beta pathway and the NF-kappa-B pathway.

ITPRID2 is also thought to be involved in the regulation of cell survival and has been shown to play a role in the regulation of cell apoptosis. It has been shown to interact with several different signaling pathways, including the PI3K/Akt pathway and the p53 pathway.

Drug targeting and biomarker potential

The potential drug targeting of ITPRID2 is significant due to its involvement in the regulation of multiple immune and inflammatory processes. ITPRID2 has been shown to play a role in the regulation of T cell responses and has been shown to interact with several different signaling pathways, making it an attractive target for small molecules and other therapeutic agents.

In addition to its potential as a drug target, ITPRID2 has also been identified as a potential biomarker for several diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. The ability to target ITPRID2 with small molecules or other therapeutic agents has the potential to improve our understanding of these diseases and to develop new treatments.

Conclusion

In conclusion, ITPRID2 is a protein that is expressed in various tissues of the body and is involved in the regulation of multiple immune and inflammatory processes. Its potential drug targeting and biomarker potential make it an attractive target for small molecules and other therapeutic agents. Further research is needed to fully understand the function of ITPRID2 and to develop new treatments for diseases in which it is involved.

Protein Name: ITPR Interacting Domain Containing 2

The "ITPRID2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ITPRID2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets